Events
Kubin, Gleave and the ACLU: Are Genes Unpatentable?
Wednesday, September 23, 2009
7:30 - 8:00 am PDT - Registration and breakfast
8:00 - 9:30 am PDT - Roundtable discussion
McDermott Will & Emery LLP
11682 El Camino Real, Suite 400
San Diego, CA 92130
View Map
To register, please click here.
The U.S. Court of Appeals for the Federal Circuit continues to change the rules for. In its recent Kubin and Gleave decisions, the Federal Circuit has changed the rules for life science and pharmaceutical companies with DNA sequence patents. Perhaps sensing the change of the tide, the ACLU recently filed a lawsuit against Myriad Genetics and other entities asking the court to declare gene patents unconstitutional.
Join McDermott partners William Gaede; David A. Gay, Ph.D.; and Andrew Kumamoto, Ph.D. for an interactive discussion of how these Federal Circuit cases have changed the assessment of gene patents, what the ACLU suit may mean for patenting DNA and other molecules isolated from nature, and how these developments may combine with pending biosimilar legislation to alter the competitive landscape for biological drugs.
McDermott Speakers
William Gaede, Partner, McDermott Will & Emery LLP
David A. Gay, Ph.D., Partner, McDermott Will & Emery LLP
Andrew Kumamoto, Ph.D., Partner, McDermott Will & Emery LLP
Key Cases and Topics
- How has Kubin affected obviousness for gene patents?
- How has Gleave affected anticipation of gene patents in view of the human genome project?
- Will the courts agree with the ACLU that gene patents are unconstitutional?
- Does the ACLU suit pose a threat to the patenting of other molecules isolated from nature?
For more information, please contact Jill Stolarik at +1 866 705 9676 or jillstolarik@mwe.com.
This program has been approved for CLE credit in California, Illinois, New York and Texas. A certificate of attendance will be made available for all other states.
McDermott Will & Emery's IP Management Roundtables are designed for the educational benefit of a company president, CEO, general counsel or other executive with an interest in intellectual property. Please be advised McDermott has the right to restrict attendance and may limit participation in this event.
